Viruses and interferon: a fight for supremacy
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The action of interferons (IFNs) on virus-infected cells and surrounding tissues elicits an antiviral state that is characterized by the expression and antiviral activity of IFN-stimulated genes. In turn, viruses encode mechanisms to counteract the host response and support efficient viral replication, thereby minimizing the therapeutic antiviral power of IFNs. In this review, we discuss the interplay between the IFN system and four medically important and challenging viruses -- influenza, hepatitis C, herpes simplex and vaccinia -- to highlight the diversity of viral strategies. Understanding the complex network of cellular antiviral processes and virus-host interactions should aid in identifying new and common targets for the therapeutic intervention of virus infection. This effort must take advantage of the recent developments in functional genomics, bioinformatics and other emerging technologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pivotal study in 1987 reported that a subpopulation of people with viral hepatitis treated with interferon (IFN) α — a pro-inflammatory anti-viral cytokine13 — developed depression14, demonstrating that a pro-inflammatory molecule in the periphery could directly influence mood.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [13]
In the citing paper
“The ISG expression of all monocytes combined and all macrophages combined was higher in HCV infection compared with NS–SS and MASH (Extended Data Fig. 4e), consistent with the role of ISGs as antiviral effectors11.”
In the citing paper
“Neutrophil recruitment is induced mainly by epithelium-derived IL-8/CXCL8, Gro-α/CXCL1, and ENA-78/CXCL5 (142, 178, 223).”
From The airway epithelium: soldier in the fight against respiratory viruses (2011) · cites this paper as [142]
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., et al. (2000) · Nature · doi:10.1038/35001009 · Cited by 4,706 · cited 1×
“, and to characterize global protein–protein interaction networks in an organis”
BackgroundVirus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · cited 1×
“gif" NDATA ITEM> ]> Interferons (IFNs), although best known for their antiviral propertie”
Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050 · cited 1×
“This confluence of genomic and information technologies brings a powerful new approach to the study of biological systems, as exemplified by recent studie”
BackgroundDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Together, these technologies provide a global perspective on the complex interactions that occur between all levels of biological information ('systems biology'), from gene expression to protein productio”
Background
Research works printed but not linked: 7
- Biron, C. A. & Sen, G. C. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 321–352 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Witherell, G. W. & Beineke, P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J. Med. Virol. 63, 8–16 (2001). · doi:10.1002/1096-9071(200101)63:1<8::aid-jmv1001>3.0.co;2-k
- Sumpter, R. Jr & Gale, M. Jr. in American Society for Virology 21st Annual Meeting W33-3 (Lexington, Kentucky, 2002).
- Whitley, R. J. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2461–2509 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Roizman, B. & Knipe, D. M. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2399–2460 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Esposito, J. J. & Fenner, F. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2849–2884 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Moss, B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2885–2922 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
Cited by
Items 101–200 of 1,000
Wang, C., Pflugheber, J., Sumpter, R., Sodora, D. L., Hui, D., Sen, G. C., & Gale, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.3898-3912.2003 · Cited by 231
“This regulation results in higher viral loads and may contribute a level of resistance against the antiviral actions of IFN (24).”
BackgroundSelf-citationHelbig, K. J., Lau, D. T.-Y., Semendric, L., Harley, H. A. J., & Beard, M. R. (2005) · Hepatology · doi:10.1002/hep.20844 · Cited by 231
Mogensen, T. H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03047 · Cited by 231
Ku, C.-C., Zerboni, L., Ito, H., Graham, B. S., Wallace, M., & Arvin, A. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040634 · Cited by 231
“HSV, a human alphaherpesvirus closely related to VZV, has several such mechanisms (17).”
BackgroundRoth-Cross, J. K., Bender, S. J., & Weiss, S. R. (2008) · Journal of Virology · doi:10.1128/jvi.01199-08 · Cited by 227
“Therefore, it is not surprising that many viruses have developed mechanisms to subvert or alter the type I IFN response, making it more difficult for the host to combat viral infection (8, 20).”
BackgroundSt. John, A. L., Rathore, A. P. S., Yap, H., Ng, M.-L., Metcalfe, D. D., Vasudevan, S. G., & Abraham, S. N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105079108 · Cited by 226
“Because genes stimulated by type I interferons can have broad influence on both innate and adaptive immune responses (29), activation of IFN-response genes in MCs is likely to promote viral containment in the host.”
BackgroundGoossens, P., Gijbels, M. J. J., Zernecke, A., Eijgelaar, W., Vergouwe, M. N., van der Made, I., Vanderlocht, J., Beckers, L., Buurman, W. A., Daemen, M. J. A. P., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.06.008 · Cited by 225
“They induce antiviral responses (Borden et al., 2007; Katze et al., 2002), have immunomodulating activities, and are clinically used to treat viral diseases, multiple sclerosis, and certain tumors (Borden et al.”
BackgroundThe Role of Viperin in the Innate Antiviral Response
Helbig, K. J., & Beard, M. R. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.10.019 · Cited by 222
Negishi, H., Osawa, T., Ogami, K., Ouyang, X., Sakaguchi, S., Koshiba, R., Yanai, H., Seko, Y., Shitara, H., Bishop, K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810372105 · Cited by 221
“Indeed, mice deficient in type I IFN signaling succumb to various viruses, whether acutely or chronically infected, because of defects in mounting effective innate and/or adaptive immune responses (5, 6).”
BackgroundEmerging Roles for Lipid Droplets in Immunity and Host-Pathogen Interactions
Saka, H. A., & Valdivia, R. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-153958 · Cited by 220
“To exert their antimicrobial activity, IFNs modulate the expression of hundreds of IFN-stimulated genes (Katze et al. 2002).”
BackgroundMenachery, V. D., Yount, B. L., Josset, L., Gralinski, L. E., Scobey, T., Agnihothram, S., Katze, M. G., & Baric, R. S. (2014) · Journal of Virology · doi:10.1128/jvi.03571-13 · Cited by 212
“…to infection begins with recognition of viral intermediates by sensor molecules that induce type I interferon (IFN); IFN signaling then regulates infection through production of several hundred interferon-stimulated genes (ISGs) that initiate an antiviral state and limit virus replication (27–29).”
BackgroundSelf-citationHelbig, K. J., Eyre, N. S., Yip, E., Narayana, S., Li, K., Fiches, G., McCartney, E. M., Jangra, R. K., Lemon, S. M., & Beard, M. R. (2011) · Hepatology · doi:10.1002/hep.24542 · Cited by 211
Ladiges, W. C., Knoblaugh, S. E., Morton, J. F., Korth, M. J., Sopher, B. L., Baskin, C. R., MacAuley, A., Goodman, A. G., LeBoeuf, R. C., & Katze, M. G. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1074 · Cited by 211
Self-citationShaw, M. L., Cardenas, W. B., Zamarin, D., Palese, P., & Basler, C. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6078-6088.2005 · Cited by 209
Central regulation of stress-evoked peripheral immune responses
Chan, K. L., Poller, W. C., Swirski, F. K., & Russo, S. J. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00729-2 · Cited by 207
Recent Advances in Engineered Materials for Immunotherapy‐Involved Combination Cancer Therapy
Liang, J., Luo, G., Chen, W., & Zhang, X. (2021) · Advanced Materials · doi:10.1002/adma.202007630 · Cited by 203
SIMMONDS, P., TUPLIN, A., & EVANS, D. J. (2004) · RNA · doi:10.1261/rna.7640104 · Cited by 203
Species-specific Regulation of Toll-like Receptor 3 Genes in Men and Mice
Heinz, S., Haehnel, V., Karaghiosoff, M., Schwarzfischer, L., Müller, M., Krause, S. W., & Rehli, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301476200 · Cited by 202
Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients
Jouan, Y., Guillon, A., Gonzalez, L., Perez, Y., Boisseau, C., Ehrmann, S., Ferreira, M., Daix, T., Jeannet, R., François, B., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200872 · Cited by 200
Sendai virus defective-interfering genomes and the activation of interferon-beta
Strahle, L., Garcin, D., & Kolakofsky, D. (2006) · Virology · doi:10.1016/j.virol.2006.03.022 · Cited by 197
Keller, B. C., Fredericksen, B. L., Samuel, M. A., Mock, R. E., Mason, P. W., Diamond, M. S., & Gale, M. (2006) · Journal of Virology · doi:10.1128/jvi.00768-06 · Cited by 198
“Taken together, these results imply that the normally avirulent phenotype of MAD78 (3, 23, 35) is due to overall reduced replication fitness and an inability of viral proteins to direct an effective JAK-STAT signaling blockade within the host cell.”
BackgroundSelf-citationThompson, L. J., Kolumam, G. A., Thomas, S., & Murali-Krishna, K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1746 · Cited by 197
“This is further confounded by the fact that LCMV is not known to have evolved any IFN antagonistic mechanisms whereas VV encodes soluble IFN-IR-like molecules to decrease the biologically available IFN-I (8, 25).”
BackgroundAbate, D. A., Watanabe, S., & Mocarski, E. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.10995-11006.2004 · Cited by 197
“IFN-/ has also been recognized as a major regulator of the adaptive immune response (6, 7). Induction of IFN-/ expression may be mediated by a number of transcription factors such as NF-B and AP-1; however, the activation of IRF-3 is believed to be the key signal to initiate IFN- transcription and the IFN-/ response (…”
BackgroundKuenzel, S., Till, A., Winkler, M., Häsler, R., Lipinski, S., Jung, S., Grötzinger, J., Fickenscher, H., Schreiber, S., & Rosenstiel, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900557 · Cited by 196
“The secretion of the cytokine IFN-g is a pivotal cellular response to viral infection (25).”
BackgroundCell-Mediated Immunity and the Outcome of Hepatitis C Virus Infection
Shoukry, N. H., Cawthon, A. G., & Walker, C. M. (2004) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123836 · Cited by 193
Mini ReviewHuman Interferons Alpha, Beta and Omega
Bekisz, J., Schmeisser, H., Hernandez, J., Goldman, N. D., & Zoon, K. C. (2004) · Growth Factors · doi:10.1080/08977190400000833 · Cited by 194
“4 and Katze et al., 2002).”
IFN-λ: Novel Antiviral Cytokines
Ank, N., West, H., & Paludan, S. R. (2006) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.26.373 · Cited by 193
MasterCARD: a priceless link to innate immunity
Hiscott, J., Lin, R., Nakhaei, P., & Paz, S. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.12.003 · Cited by 192
Lin, R.-J., Liao, C.-L., Lin, E., & Lin, Y.-L. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9285-9294.2004 · Cited by 191
“To initiate viral replication and production of progeny virus, many viruses have evolved different strategies to circumvent the host IFN- / response, such as inhibition of IFN production and signaling and blocking of the functions of IFNinduced proteins (15, 28, 41, 50, 52).”
Backgroundde los Santos, T., de Avila Botton, S., Weiblen, R., & Grubman, M. J. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1906-1914.2006 · Cited by 189
“Most viruses have developed mechanisms to escape the IFN system (1, 9, 15, 16, 20, 51).”
BackgroundInterferons: mechanisms of action and clinical applications
Parmar, S., & Platanias, L. C. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00005 · Cited by 190
Toll‐Like Receptor 3: A Link between Toll‐Like Receptor, Interferon and Viruses
Matsumoto, M., Funami, K., Oshiumi, H., & Seya, T. (2004) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2004.tb03500.x · Cited by 189
Hartmann, R., Justesen, J., Sarkar, S. N., Sen, G. C., & Yee, V. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00433-7 · Cited by 182
Innate immunity and toll-like receptors: clinical implications of basic science research
Abreu, M. T., & Arditi, M. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.01.057 · Cited by 182
Fullam, A., & Schröder, M. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.03.012 · Cited by 180
Innate sensing of self and non-self RNAs by Toll-like receptors
Sioud, M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.02.004 · Cited by 179
Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier
Wang, F., Ma, Y., Barrett, J. W., Gao, X., Loh, J., Barton, E., Virgin, H. W., & McFadden, G. (2004) · Nature Immunology · doi:10.1038/ni1132 · Cited by 180
“The expression of type I interferon requires multiple cellular transcription factor”
BackgroundCoronavirus virulence genes with main focus on SARS-CoV envelope gene
DeDiego, M. L., Nieto-Torres, J. L., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Castaño-Rodriguez, C., Fernandez-Delgado, R., Usera, F., & Enjuanes, L. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.024 · Cited by 177
Liu, W. J., Chen, H. B., Wang, X. J., Huang, H., & Khromykh, A. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12225-12235.2004 · Cited by 177
“Transcription factors involved in activation of IFN- gene transcription may be induced by viruses through a number of different pathways, with the interferon regulatory factor 3 (IRF-3) pathway being the most prominent (11, 15, 22, 43).”
Background(2015) · Diagnostic Pathology: Infectious Diseases · doi:10.1016/b978-0-323-37677-8.50024-3 · Cited by 172
Perri, S., Greer, C. E., Thudium, K., Doe, B., Legg, H., Liu, H., Romero, R. E., Tang, Z., Bin, Q., Dubensky, T. W., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10394-10403.2003 · Cited by 172
Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation
Devaux, P., von Messling, V., Songsungthong, W., Springfeld, C., & Cattaneo, R. (2007) · Virology · doi:10.1016/j.virol.2006.09.049 · Cited by 171
“For example, Paramyxoviruses not only block the synthesis of IFNα/β, but also inhibit signal transduction in response to IFNα/β by effecting the molecules involved in the JAK/STAT pathway (Garcia-Sastre, 2002; Hengel et al., 2005; Katze et al., 2002).”
BackgroundHelbig, K. J., Carr, J. M., Calvert, J. K., Wati, S., Clarke, J. N., Eyre, N. S., Narayana, S. K., Fiches, G. N., McCartney, E. M., & Beard, M. R. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002178 · Cited by 172
IFN-Induced TPR Protein IFIT3 Potentiates Antiviral Signaling by Bridging MAVS and TBK1
Liu, X.-Y., Chen, W., Wei, B., Shan, Y.-F., & Wang, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100963 · Cited by 169
“However, the use of cell lines with appropriate genetic deficiencies of JAKSTAT pathway components demonstrated that viral and bacterial molecular patterns can directly (i.e., independently of IFN action) induce transcription of a subset of ISGs, including IFIT family genes (38, 39).”
BackgroundInfluentialRegulation of CD1d expression and function by a herpesvirus infection
Sanchez, D. J., Gumperz, J. E., & Ganem, D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524041 · Cited by 170
Mathematical models for dengue fever epidemiology: A 10-year systematic review
Aguiar, M., Anam, V., Blyuss, K. B., Estadilla, C. D. S., Guerrero, B. V., Knopoff, D., Kooi, B. W., Srivastav, A. K., Steindorf, V., & Stollenwerk, N. (2022) · Physics of Life Reviews · doi:10.1016/j.plrev.2022.02.001 · Cited by 163
“With a model framework including a class of natural killer cells N and interferon F , a group of signaling proteins produced and released by host cells in response to the presence of several viruses [128], the authors have investigated three models with increasing complexity.”
Review: Enhancement and Diversification of IFN Induction by IRF-7-Mediated Positive Feedback
Levy, D. E., Marié, I., Smith, E., & Prakash, A. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452692 · Cited by 167
Loures, F. V., Röhm, M., Lee, C. K., Santos, E., Wang, J. P., Specht, C. A., Calich, V. L. G., Urban, C. F., & Levitz, S. M. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004643 · Cited by 165
“Binding the promoter element leads to an increased expression of interferon-stimulated genes (ISGs) [37].”
BackgroundIntracellular Pathogen Detection by RIG-I-Like Receptors
Dixit, E., & Kagan, J. C. (2013) · Advances in Immunology · doi:10.1016/b978-0-12-410524-9.00004-9 · Cited by 165
Ramaswamy, M., Shi, L., Varga, S. M., Barik, S., Behlke, M. A., & Look, D. C. (2006) · Virology · doi:10.1016/j.virol.2005.09.009 · Cited by 165
“Many genes are induced by type I interferon, but several, including MxA, 2V,5V-oligoadenylate synthase (2,5-OAS), and protein kinase R (PKR), are more specific to type I interferon and have antiviral properties that are particularly important for establishment of a host cell antiviral state ( Katze et al., 2002 ).”
BackgroundHuman Toll‐like receptor‐dependent induction of interferons in protective immunity to viruses
Zhang, S., Jouanguy, E., Sancho‐Shimizu, V., Von Bernuth, H., Yang, K., Abel, L., Picard, C., Puel, A., & Casanova, J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00564.x · Cited by 164
“As viruses have developed multiple strategies for counteracting host antiviral IFN-mediated immunity (138, 139) , these investigations may improve our understanding of host-virus interaction and evolution.”
BackgroundHCV-related hepatocellular carcinoma: From chronic inflammation to cancer
Castello, G., Scala, S., Palmieri, G., Curley, S. A., & Izzo, F. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.10.007 · Cited by 164
The Interferon Inducible Gene: Viperin
Fitzgerald, K. A. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0127 · Cited by 163
Is RNA interference involved in intrinsic antiviral immunity in mammals?
Cullen, B. R. (2006) · Nature Immunology · doi:10.1038/ni1352 · Cited by 163
“However, in mammalian cells, long dsRNA sequences (more than 30 base pairs in length) are potent inducers of the interferon response and its various effector molecules such as PKR, which inhibits translation, and RNase L, which degrades mRN”
BackgroundThe Role of microRNAs in the Pathogenesis of Herpesvirus Infection
Piedade, D., & Azevedo-Pereira, J. (2016) · Viruses · doi:10.3390/v8060156 · Cited by 164
“Despite evidence in plants and insects, it was thought that this pathway was not antiviral in mammalian cells due to interferon system activation by viral dsRNA [18].”
BackgroundThe regulatory network behind MHC class I expression
Jongsma, M. L. M., Guarda, G., & Spaapen, R. M. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2017.12.005 · Cited by 161
Inhibition of Transcription and Translation in Sindbis Virus-Infected Cells
Gorchakov, R., Frolova, E., & Frolov, I. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9397-9409.2005 · Cited by 162
“Its development implies multiple rounds of infection that proceed in the background of the developing antiviral response, aimed at blocking the spread of infection (14, 24, 38, 41, 45).”
BackgroundInterferon Lambda: Modulating Immunity in Infectious Diseases
Syedbasha, M., & Egli, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00119 · Cited by 160
“In response, every virus has evolved specific ways to counteract IFN signaling and its effects (139) (140) (141) (142) (143) .”
BackgroundCancer stem cell mimicry for immune evasion and therapeutic resistance
Saw, P. E., Liu, Q., Wong, P., & Song, E. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.06.003 · Cited by 183
Egli, A., Santer, D. M., O’Shea, D., Tyrrell, D. L., & Houghton, M. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.51 · Cited by 160
“50 The IFN-a signaling cascade is known to be modulated at numerous points 51 and it is also very likely that co-evolutionary competition between IFNLs and different viruses has occurred.”
BackgroundHost defense function of the airway epithelium in health and disease: clinical background
Message, S. D., & Johnston, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703315 · Cited by 159
“Type 1 IFNs IFNs are thought to play an important role in innate resistance to viruses [122], acting on virus-infected cells and surrounding tissues to produce an antiviral state characterized by the expression and antiviral activity of IFN-stimulated genes (ISGs).”
BackgroundInfluentialHinson, E. R., & Cresswell, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807261200 · Cited by 158
Use of Replicating Oncolytic Adenoviruses in Combination Therapy for Cancer
Chu, R. L., Post, D. E., Khuri, F. R., & Van Meir, E. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0349-03 · Cited by 158
Frieman, M. B., Chen, J., Morrison, T. E., Whitmore, A., Funkhouser, W., Ward, J. M., Lamirande, E. W., Roberts, A., Heise, M., Subbarao, K., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000849 · Cited by 158
“Mice lacking IFN receptors show increased susceptibility to West Nile[9], influenza[12,39], Ebola[11], Friend virus[40], RSV[7,8] and Poliovirus[41] (reviewed in [42]).”
BackgroundNavratil, V., de Chassey, B., Meyniel, L., Delmotte, S., Gautier, C., André, P., Lotteau, V., & Rabourdin-Combe, C. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn794 · Cited by 157
“In order to evade the cell innate immune response and/or to favour their own replication and transmission, viruses have developed strategies to hijack central functions of the cell (5) (6) (7) .”
BackgroundHerc5 Attenuates Influenza A Virus by Catalyzing ISGylation of Viral NS1 Protein
Tang, Y., Zhong, G., Zhu, L., Liu, X., Shan, Y., Feng, H., Bu, Z., Chen, H., & Wang, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903588 · Cited by 158
“Accordingly, many viruses encode specific viral proteins to antagonize IFN-induced host antiviral activities (55, 56).”
BackgroundNovel functions of proteins encoded by viral stress-inducible genes
Sarkar, S. N., & Sen, G. C. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.07.007 · Cited by 158
Histone Deacetylase Inhibitors Augment Antitumor Efficacy of Herpes-based Oncolytic Viruses
Otsuki, A., Patel, A. K., Kasai, K., Suzuki, M., Kurozumi, K., Chiocca, E. A., & Saeki, Y. (2008) · Molecular Therapy · doi:10.1038/mt.2008.155 · Cited by 174
Weiss, G., Rasmussen, S., Zeuthen, L. H., Nielsen, B. N., Jarmer, H., Jespersen, L., & Frøkiær, H. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03301.x · Cited by 156
Vremec, D., O'Keeffe, M., Hochrein, H., Fuchsberger, M., Caminschi, I., Lahoud, M., & Shortman, K. (2007) · Blood · doi:10.1182/blood-2006-05-015354 · Cited by 155
Eriksson, K. K., Cervantes-Barragán, L., Ludewig, B., & Thiel, V. (2008) · Journal of Virology · doi:10.1128/jvi.02082-08 · Cited by 155
“Type I IFNs induce the expression of antiviral effector molecules (12, 16) but also shape the upcoming adaptive immune response (29).”
BackgroundAntiviral immunity in crustaceans
Liu, H., Söderhäll, K., & Jiravanichpaisal, P. (2009) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2009.02.009 · Cited by 172
“oligoadenylate synthetase, RNaseL, RNA-specific adenosine deaminase ADAR and IFNs themselves [114].”
Alff, P. J., Gavrilovskaya, I. N., Gorbunova, E. E., Endriss, K., Chong, Y., Geimonen, E., Sen, N., Reich, N. C., & Mackow, E. R. (2006) · Journal of Virology · doi:10.1128/jvi.00508-06 · Cited by 167
“To negotiate cellular defenses, viruses have developed mechanisms that block dsRNA recognition, regulate cell signaling pathways that induce interferon, or compensate for ISG functions (5, 22, 27).”
BackgroundDevelopmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection
Lewis, D. B., & Wilson, C. B. (2006) · Elsevier eBooks · doi:10.1016/b0-72-160537-0/50006-2 · Cited by 157
Aparicio, O., Razquin, N., Zaratiegui, M., Narvaiza, I., & Fortes, P. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1376-1384.2006 · Cited by 168
“dsRNA activates PKR, which phosphorylates the subunit of eukaryotic initiation factor 2 (eIF-2 ) (21).”
Characterization of Snakehead Rhabdovirus Infection in Zebrafish ( Danio rerio )
Phelan, P. E., Pressley, M. E., Witten, P. E., Mellon, M. T., Blake, S., & Kim, C. H. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1842-1852.2005 · Cited by 150
“IFN induces an antiviral state in which host cells block mRNA transcription and translation in order to prevent viral replication in infected cells (22).”
BackgroundInnate immune modulation by RNA viruses: emerging insights from functional genomics
Katze, M. G., Fornek, J. L., Palermo, R. E., Walters, K., & Korth, M. J. (2008) · Nature reviews. Immunology · doi:10.1038/nri2377 · Cited by 159
“All RNA viruses encode proteins that are essential for structural components and replication, and most encode proteins that function to circumvent host antiviral responses [1] [2] [3] .”
BackgroundSelf-citationInterferon regulatory factor family of transcription factors and regulation of oncogenesis
Takaoka, A., Tamura, T., & Taniguchi, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00720.x · Cited by 172
Hwang, S., Kim, K. S., Flaño, E., Wu, T.-T., Tong, L. M., Park, A. N., Song, M. J., Sanchez, D. J., O’Connell, R. M., Cheng, G., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2008.12.013 · Cited by 162
“For efficient IFN response, IFN-b-producing cells mainly rely on autocrine feedback, but IFN-a-producing cells constitutively express IRF-7 to rapidly produce high levels of IFN-a (Mossman and Ashkar, 2005).”
InfluentialYoo, D., Song, C., Sun, Y., Du, Y., Kim, O., & Liu, H. (2010) · Virus Research · doi:10.1016/j.virusres.2010.07.019 · Cited by 162
Carbon dots as inhibitors of virus by activation of type I interferon response
Du, T., Liang, J., Dong, N., Liu, L., Fang, L., Xiao, S., & Han, H. (2016) · Carbon · doi:10.1016/j.carbon.2016.09.032 · Cited by 149
Multiple signaling pathways leading to the activation of interferon regulatory factor 3
Servant, M. J., Grandvaux, N., & Hiscott, J. B. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01165-6 · Cited by 167
Viruses and antiviral immunity in Drosophila
Xu, J., & Cherry, S. R. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.05.002 · Cited by 158
The JAK-STAT pathway: from structural biology to cytokine engineering
Lv, Y., Qi, J., Babon, J. J., Cao, L., Fan, G.-H., Lang, J., Zhang, J., Mi, P., Kobe, B., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01934-w · Cited by 177
Dendritic Cells Control B Cell Growth and Differentiation
Jégo, G., Pascual, V., Palucka, A. K., & Banchereau, J. (2004) · KARGER eBooks · doi:10.1159/000082101 · Cited by 162
Biering, S. B., Sarnik, S. A., Wang, E., Zengel, J. R., Leist, S. R., Schäfer, A., Sathyan, V., Hawkins, P., Okuda, K., Tau, C., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01131-x · Cited by 142
“…involves activation of cell death programs, production of proinflammatory cytokines via the nuclear factor kappa-light-chain-enhancer of B cells (NF-κB) signaling pathway, and upregulation of type I interferons (IFN), which regulate expression of numerous interferon-stimulated genes (ISGs) 3,4 .”
Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C
Pawlotsky, J. (2003) · Antiviral Research · doi:10.1016/s0166-3542(03)00088-3 · Cited by 143
Viruses as Modulators of Mitochondrial Functions
Anand, S. K., & Tikoo, S. K. (2013) · Advances in Virology · doi:10.1155/2013/738794 · Cited by 157
“Cells respond to virus attack by activating a variety of signal transduction pathways leading to the production of interferons [217], which limit or eliminate the invading virus.”
BackgroundPerry, S. T., Buck, M. D., Lada, S. M., Schindler, C., & Shresta, S. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001297 · Cited by 141
“to induce the expression of IFN-stimulated genes (ISGs) [6].”
BackgroundFredericksen, B. L., Smith, M. W., Katze, M. G., Shi, P., & Gale, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7737-7747.2004 · Cited by 150
“The mechanisms used by various viruses to neutralize the antiviral programs are extremely divergent (23).”
BackgroundSelf-citationMoraes, M. P., Santos, T. D. L., Koster, M. J., Turecek, T., Wang, H., Andreyev, V. G., & Grubman, M. J. (2007) · Journal of Virology · doi:10.1128/jvi.02775-06 · Cited by 147
“However, like other viruses, FMDV has evolved multiple mechanisms to overcome the IFN- / response (7, 21, 23, 26, 31, 42, 76).”
BackgroundJin, J., Hu, H., Li, H. S., Yu, J., Xiao, Y., Brittain, G. C., Zou, Q., Cheng, X., Mallette, F. A., Watowich, S. S., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.006 · Cited by 138
Innate immune responses in hepatitis B virus (HBV) infection
Busca, A., & Kumar, A. (2014) · Virology Journal · doi:10.1186/1743-422x-11-22 · Cited by 162
“The main sources of IFN-α/β are infected cells and plasmacytoid dendritic cells, whereas IFN-γ is produced primarily by NK and NKTcells [13].”
BackgroundInnate Immune Responses to Dengue Virus
Navarro-Sánchez, E., Desprès, P., & Cedillo‐Barrón, L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.04.007 · Cited by 162
Loving, C. L., Brockmeier, S. L., & Sacco, R. E. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02493.x · Cited by 178
“18 Once produced, IFN-a/b can induce dendritic cell (DC) maturation 19 and act as a survival factor for activated T cells.”
McBeath, A., SNOW, M., Secombes, C. J., ELLIS, A., & Collet, B. (2006) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2006.05.004 · Cited by 156
Fish health aspects in grouper aquaculture
Harikrishnan, R., Balasundaram, C., & Heo, M. (2011) · Aquaculture · doi:10.1016/j.aquaculture.2011.07.022 · Cited by 139
Anti-viral protein APOBEC3G is induced by interferon-α stimulation in human hepatocytes
Tanaka, Y., Marusawa, H., Seno, H., Matsumoto, Y. M., Ueda, Y., Kodama, Y., Endo, Y., Yamauchi, J., Matsumoto, T., Takaori‐Kondo, A., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.192 · Cited by 137
Bovine Herpesvirus Type 1 (BHV-1) is an Important Cofactor in the Bovine Respiratory Disease Complex
Jones, C., & Chowdhury, S. I. (2010) · Veterinary Clinics of North America Food Animal Practice · doi:10.1016/j.cvfa.2010.04.007 · Cited by 167
Type III Interferons in Viral Infection and Antiviral Immunity
Zhou, J.-H., Wang, Y.-N., Chang, Q.-Y., Ma, P., Hu, Y., & Cao, X. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495172 · Cited by 135
Metadata
- Authors
- Katze, M. G., He, Y., & Gale, M.
- Affiliations
- University of Washington (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Katze, Michael G.
- Venue
- Nature Reviews Immunology
- Published
- 2002-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 675-687
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2079295092
- Cited by
- 1,419
- References
- 138
- Citations by year
- 2026: 30 · 2025: 62 · 2024: 89 · 2023: 82 · 2022: 67 · 2021: 48 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 38 · 2016: 41 · 2015: 40 · 2014: 55 · 2013: 58 · 2012: 55
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon, antiviral immunity, host-virus interaction, interferon-stimulated genes, viral evasion of host defense, influenza virus, hepatitis C virus, herpes simplex virus, vaccinia virus, antiviral drug targets
- MeSH terms
- Animals, Hepatitis C, Herpes Simplex, Humans, Interferon Type I, Membrane Glycoproteins, Orthomyxoviridae, Orthomyxoviridae Infections, Receptors, Cell Surface, Vaccinia, Vaccinia virus, Virus Diseases, Virus Replication, Hepacivirus, Simplexvirus, Computational Biology, Databases as Topic, Genomics, Drosophila Proteins, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.